Review paper

Current and emerging pharmacotherapy for ischemic stroke prevention in patients with atrial fibrillation

Volume: 19, Issue: 18, Pages: 1999 - 2009
Published: Oct 25, 2018
Abstract
Introduction Atrial fibrillation (AF) is associated with high morbidity and mortality rates due to thromboembolic complications, and anticoagulation is central to the management of this common arrhythmia to prevent acute thromboembolic events. The traditional anticoagulants: heparin, fondaparinux, and vitamin K antagonists (VKA, e.g. warfarin, acenocoumarol or phenprocoumin) have long served as pharmacotherapy for ischemic stroke prophylaxis....
Paper Details
Title
Current and emerging pharmacotherapy for ischemic stroke prevention in patients with atrial fibrillation
Published Date
Oct 25, 2018
Volume
19
Issue
18
Pages
1999 - 2009
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.